This inventor holds 1 USPTO granted patent. Top assignee: Fujirebio Inc.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Masakatsu Matumoto: Innovator in Cholesterol-Reducing Agents
Introduction
Masakatsu Matumoto is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholesterol-reducing agents. His innovative work has implications for treating conditions such as arteriosclerosis.
Latest Patents
Masakatsu Matumoto holds a patent for 4-hydroxytetrahydropyran-2-one derivatives. This patent describes compounds that serve as inhibitors of HMG-CoA reductase, which are effective in reducing cholesterol and lipid levels. The general formula of these derivatives includes various substituents that enhance their efficacy in inhibiting the biosynthesis of peroxidized lipids.
Career Highlights
Matumoto is associated with Fujirebio Inc., where he has been instrumental in advancing research related to lipid metabolism. His work has led to the development of innovative therapeutic agents that address critical health issues.
Collaborations
He has collaborated with notable colleagues such as Jun Kusunoki and Nobuko Watanabe, contributing to a dynamic research environment that fosters innovation.
Conclusion
Masakatsu Matumoto's contributions to the field of cholesterol-reducing agents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact health and wellness through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile